{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15"],"submitter":["Reineke M"],"pubmed_abstract":["<h4>Background</h4>Torque teno virus load (TTVL) is gaining importance as a surrogate parameter to assess immunocompetence in kidney transplant recipients. Although the dynamics of TTVL have been investigated before, the impact of different induction agents and variations in immunosuppressive maintenance therapies on TTVL remain unknown.<h4>Methods</h4>In this retrospective study, TTVL was quantified in 537 plasma or serum samples from 134 patients transplanted between 2018 and 2021. TTVL was examined pre-transplantation and 30-, 90-, 180-, and 360-days post-transplant. To assess the influence of induction therapy on TTVL, 67 patients receiving anti-thymocyte globulin (ATG) induction were matched with 67 patients receiving an interleukin-2 receptor antagonist (IL2-RA) induction in terms of"],"journal":["Frontiers in immunology"],"pagination":["1492611"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11599233"],"repository":["biostudies-literature"],"pubmed_title":["Impact of induction agents and maintenance immunosuppression on torque teno virus loads and year-one complications after kidney transplantation."],"pmcid":["PMC11599233"],"pubmed_authors":["Loi L","Benning L","Reineke M","Klein JAF","Bundschuh C","Schnitzler P","Zeier M","Speer C","Sommerer C","Morath C"],"additional_accession":[]},"is_claimable":false,"name":"Impact of induction agents and maintenance immunosuppression on torque teno virus loads and year-one complications after kidney transplantation.","description":"<h4>Background</h4>Torque teno virus load (TTVL) is gaining importance as a surrogate parameter to assess immunocompetence in kidney transplant recipients. Although the dynamics of TTVL have been investigated before, the impact of different induction agents and variations in immunosuppressive maintenance therapies on TTVL remain unknown.<h4>Methods</h4>In this retrospective study, TTVL was quantified in 537 plasma or serum samples from 134 patients transplanted between 2018 and 2021. TTVL was examined pre-transplantation and 30-, 90-, 180-, and 360-days post-transplant. To assess the influence of induction therapy on TTVL, 67 patients receiving anti-thymocyte globulin (ATG) induction were matched with 67 patients receiving an interleukin-2 receptor antagonist (IL2-RA) induction in terms of","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024","modification":"2025-04-04T02:45:27.206Z","creation":"2025-04-04T02:45:27.206Z"},"accession":"S-EPMC11599233","cross_references":{"pubmed":["39606231"],"doi":["10.3389/fimmu.2024.1492611"]}}